Corona Remedies Limited, incorporated in August 2004, develops, manufactures, and markets pharmaceutical products. The company’s diverse portfolio featured 71 brands as of June 30, 2025, focused on women’s healthcare, cardio-diabetes, pain, urology, and other specialties.

Its nationwide reach is driven by 2,671 medical representatives across 22 states, facilitating strong engagement with the medical community. Production is handled at two Gujarat-based plants with a total annual capacity of 1,285.44 million units.

The initial public offering (IPO) for Corona Remedies is a book-built issue scheduled to open on December 8, 2025, and close on December 10, 2025. Priced between ₹1,008 and ₹1,062 per share, the IPO aims to raise approximately ₹655.37 crores through a combination of a fresh issue and an offer for sale of up to 61,71,101 equity shares, each with a face value of ₹10. The allocation is reserved with 35% for retail investors, 50% for qualified institutional buyers (QIBs), and 15% for high net-worth individuals (HNIs).

The basis of allotment is expected on December 11, 2025, followed by the listing on both the BSE and NSE on December 15, 2025. Financially, the company has demonstrated strong growth, with revenue rising to ₹1,202.35 crores in 2025 from ₹1,020.93 crores in 2024, and profit increasing to ₹149.43 crores from ₹90.50 crores over the same period.

Corona Remedies IPO Details

IPO Date	December 8, 2025 to December 10, 2025
Listing Date	[.]
Face Value	₹10 per share
IPO Price Band	₹1008 to ₹1062 Per Share
Issue Price	₹1062 per share
Lot Size	14 Shares
Total Issue Size	Approx ₹655.37 Crores
Offer for Sale	Approx 61,71,101 Equity Shares
Issue Type	Book building IPO
Listing At	BSE, NSE
Share Holding Pre Issue	6,11,60,088 shares
Share Holding Post Issue	6,11,60,088 shares

Corona Remedies IPO Dates

The initial public offering (IPO) for Corona Remedies will open on Monday, December 8, 2025, and will close on Wednesday, December 10, 2025.

IPO Open Date	Mon, Dec 8, 2025
IPO Close Date	Wed, Dec 10, 2025
Tentative Allotment	Thu, Dec 11, 2025
Refunds	Fri, Dec 12, 2025
Credit of Shares to Demat	Fri, Dec 12, 2025
Tentative Listing Date	Mon, Dec 15, 2025
UPI Mandate Confirmation Deadline	5 PM on Wed, Dec 10, 2025

Corona Remedies IPO Market Lot

The minimum application for the IPO is set at one lot of 14 shares, priced at ₹14,868. The upper limit for retail investors is 13 lots, equivalent to 182 shares, for a maximum amount of ₹1,93,284.

Application	Lot Size	Shares	Amount
Retail Minimum	1	14	₹14,868
Retail Maximum	13	182	₹1,93,284
S-HNI Minimum	14	196	₹2,08,152
S-HNI Maximum	67	938	₹9,96,156
B-HNI Minimum	68	952	₹10,11,024

Know more

Corona Remedies IPO Guide: Dates, Price, GMP & More